Entia Liberty: Home Study

Launched by ENTIA LTD · Jul 13, 2022

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18
• • Adequate English language skills (not requiring a translator) to participate in participant training and use the Liberty device
• • Patients willing and able to perform capillary blood self-testing at the same frequency as routine full blood count monitoring
• • Patients capable of providing informed consent before attending training
• • Patients able to attend a 1-hour virtual training session within 2 weeks of joining the study
• • Patients with a home Wi-Fi network or with adequate coverage at home via a 4G network
• • Patients with access to a laptop or smartphone to facilitate training
• • Patients with a diagnosis of ovarian or breast cancer
• • Patients whose HCPs can confirm are undergoing systemic anti-cancer treatments within two weeks of enrolment, with treatment expected to continue for at least two cycles
• Exclusion Criteria:
• • Patients with haematological malignancies
• • Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Liberty device or participation in training unless they have a nominated caregiver who is capable of assisting with each test